Overview

A Multiple-dose Study in Chinese Subjects to Evaluate Safety,Tolerability,PK and PD of ZM-H1505R

Status:
Completed
Trial end date:
2021-11-17
Target enrollment:
Participant gender:
Summary
This phase Ib study included two parts in which Part I was to evaluate the safety and bridge for PK among healthy Chinese subjects and Part II were about study among Chinese chronic hepatitis B virus-infected patients. Study of Part II was carried out following the safety assessment and racial difference evaluation in Part I.
Phase:
Phase 1
Details
Lead Sponsor:
Shanghai Zhimeng Biopharma, Inc.